Introduction Coronavirus disease 2019 (COVID-19) is prevalent among young people, and
neurological involvement has been reported. We investigated neurological symptoms, …

… patients, although we found no differences between COVID-19 hospitalized and non-hospitalized …
Some have suggested the possibility that COVID-19 infectious environment may …

… , non-hospitalized patients with mild–moderate COVID-19. To strengthen the statistical
power of the analyses, and allow more robust inference around well-defined clinical end points …

… In conclusion, our study supports the use of molnupiravir in non-hospitalized patients with
COVID-19. Further research should be focused on evaluating its comparative efficacy in …

… in COVID-19 patients. The aim of the study therefore is to investigate different types of
oral manifestations in COVID-19 patients as well as their prevalence. Patients and Methods …

… OD and GD in a cohort of patients with confirmed COVID-19. The evaluation focused on the
rate … in a recent paper assessing patients with OD and/or GD during the COVID-19 epidemic. …

… Since COVID-19 can cause damage to this system, long-term sequelae might alter control
… This study aimed to evaluate the postural balance of patients with post-acute COVID-19 …

… Reducing the variation in the description is paramount in order to establish a common
understanding of the prevalence of specific symptoms after COVID-19 [2]. In our manuscript, we …

… Results: Our sample consisted of 141 COVID-19 inpatients, 99 COVID-19 quarantined patients,
… was higher in COVID-19 hospitalized than in COVID-19 non-hospitalized patients than in …

… the prefrontal and subcortical nuclei of non-hospitalized COVID-19 patients (16). It is also
aligned with a study comparing mild and severe forms of COVID-19, where the latter group had …